Search Results for: Tilray
Tilray Stockholders Approve Proposal to Increase Authorized Shares at Special Meeting
Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged…
Tilray Chairman and CEO, Irwin Simon, Sends Shareholder Letter Mapping out $4B Revenue Plan
Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged…
Tilray Announces Adjournment of Special Meeting of Stockholders to September 10, 2021
Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged…
Tilray Acquires Majority Position in Amended MedMen Convertible Notes
Investment Provides Tilray a Potential Accelerated Path into U.S. Cannabis Market Upon Federal Legalization Amendment and Extension…
Tilray Announces Adjournment of Special Meeting of Stockholders to August 19, 2021
Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged…
Tilray, Inc. Reports 2021 Fiscal Year and Fourth Quarter Results
Net Revenue Increased 27% to $513 Million Compared to Prior Year Net Income of $33.6…
Tilray to Announce Fourth Quarter and Fiscal 2021 Financial Results on July 28, 2021
Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY; TSX: TLRY) announced that the Company will release financial…
Tilray’s Aphria RX GmbH Subsidiary Completes First Successful Harvest and Delivery of Medical Cannabis Grown in Germany
Tilray, Inc. (NASDAQ | TSX: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution,…
Tilray Announces Launch of New Medical Cannabis Brand, Symbios
Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today…
Tilray Commences Trading on the Toronto Stock Exchange Under Symbol “TLRY”
Tilray, Inc. (“Tilray”) announced that as of today, May 5, 2021, its shares of class 2 common…
Recent Comments